China Universal Asset Management Co., Ltd.
Position in LLY — ELI LILLY & Co
CIK 1906594
SHANGHAI, F4
Position in LLY
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$10,876,432
+$6,932,459 QoQ
Shares Held
9,068
+111.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,213
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $86,175,801 across 12 Drug Manufacturers - General names. LLY ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
72,203 | $26,146,150 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
161,528 | $20,407,447 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
9,068 | $10,876,432 | |
| 4 | NVS |
Novartis AG
|
49,000 | $7,679,280 | |
| 5 | JNJ |
Johnson & Johnson
|
28,214 | $7,165,509 | |
| 6 | BIIB |
Biogen Inc.
|
23,497 | $5,076,761 | |
| 7 | MRK |
Merck & Co., Inc.
|
29,663 | $3,811,695 | |
| 8 | ABBV |
AbbVie Inc.
|
6,913 | $1,739,587 |
All Filings in LLY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,876,432 | 9,068 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $3,943,973 | 4,288 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $6,553,399 | 6,098 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,314,765 | 5,655 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,041,357 | 7,750 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $5,840,835 | 7,072 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $6,033,180 | 7,815 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $7,002,469 | 7,904 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $5,660,435 | 6,252 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $7,699,470 | 9,897 | Shares | Sole | 2024-05-21 | |
| 2023-12-31 | $4,824,828 | 8,277 | Shares | Sole | 2024-05-22 | |
| 2023-09-30 | $4,445,825 | 8,277 | Shares | Sole | 2024-05-22 | |
| 2023-06-30 | $5,348,247 | 11,404 | Shares | Sole | 2024-05-22 | |
| 2023-03-31 | $4,970,317 | 14,473 | Shares | Sole | 2024-05-22 | |
| 2022-12-31 | $5,328,459 | 14,565 | Shares | Sole | 2024-05-22 | |
| 2022-09-30 | $4,166,041 | 12,884 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $1,732,685 | 5,344 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $381,158 | 1,331 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $3,997,455 | 14,472 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||